SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Varian Semiconductor Equipment Associates -- VSEA -- Ignore unavailable to you. Want to Upgrade?


To: Sherman Chen who wrote (1471)10/27/2001 10:42:39 AM
From: Proud_Infidel  Respond to of 1929
 
I did not....wanted to make sure I had all the depression meds necessary before doing so<bg>



To: Sherman Chen who wrote (1471)11/6/2001 8:45:45 AM
From: Proud_Infidel  Read Replies (4) | Respond to of 1929
 
Varian Semiconductor Wins Multiple 300mm Orders for VIISta ion Implanters
Also Chosen as a Supplier-of-Record for Single Wafer Implanters
GLOUCESTER, Mass.--(BUSINESS WIRE)--Nov. 6, 2001--Varian Semiconductor Equipment Associates, Inc. (Nasdaq: VSEA - news), the leading supplier of ion implantation systems, today announced that a major U.S. chipmaker has ordered a series of VIISta single wafer ion implanters for advanced 300mm integrated circuit manufacturing.

This multi-million dollar order highlights the broad acceptance of the VIISta platform in leading 300mm fabs worldwide.

``The major U.S. semiconductor manufacturer which placed this order has always been at the forefront of technology, leading the industry into new process applications,'' said Varian Semiconductor's chairman and chief executive officer, Richard Aurelio. ``We are pleased that this customer is developing leading edge processes enabled by our VIISta single wafer implanters to meet their 300mm production requirements.''

During the past year, Varian Semiconductor has been working closely with engineers at this chipmaker's fab to complete an extensive equipment selection and qualification process and to quantify the potential cost reduction opportunities provided by the VIISta platform. As a result of working with the single wafer VIISta 810 medium current and high tilt VIISta 80 high current systems, this chipmaker designated Varian Semiconductor as a supplier-of-record.

``Our customer reports that it pursued the best and most cost effective production technology available and after an extensive review of implanter options, has selected Varian Semiconductor's VIISta platform of implanters for its sub-130nm production requirements,'' said Ernest Godshalk, president and chief operating officer of Varian Semiconductor. ``The designation of supplier-of-record further illustrates our technology leadership in 300mm single wafer processing with the VIISta platform, and we look forward to working closely with our customer on future ion implant technologies.''

The VIISta platform of parallel beam, single wafer implanters covers the entire range of ion implantation requirements, from 200eV through 3.75 MeV. The benefits derived from the parallel beam systems center around the precise placement of dopants in the device structures. Each implanter in the platform offers specific advantages in terms of integrated circuit performance.

For high current, the VIISta 80 presents an opportunity to improve junction abruptness control and increase the drive current and processing speed. For medium current, the VIISta 810 provides exceptional control of the Vt and halo implants, improving the consistency of operating characteristics and yield across the wafer. For high energy, the VIISta 3000 provides additional accuracy in the placement of dopant species to enhance well-to-well isolation characteristics, reducing the size of the transistors and increasing the number of integrated circuits on the wafer. The VIISta 10 P2LAD ultra low energy ion implanter combines pulsed-plasma doping with the VIISta platform functionality to overcome the significant technical challenges posed by the requirements of low energy doping for ultra shallow junctions.

About Varian Semiconductor

Varian Semiconductor Equipment Associates is the leading producer of ion implantation equipment used in the manufacture of semiconductors. The company is headquartered in Gloucester, Massachusetts, and operates worldwide. Varian Semiconductor maintains a web site at www.vsea.com. The information contained in the company's web site is not incorporated by reference into this release, and the web site address is included in this release as an inactive textual reference only.

Note: This press release contains forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. For this purpose, the statements concerning the company's expectations regarding the customer discussed in this release, market share and technology leadership, technological capabilities and benefits are forward-looking statements and any statements using the terms ``believes,'' ``anticipates,'' ``expects,'' ``plans,'' or similar expressions are forward-looking statements. There are a number of important risks and factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, volatility in the semiconductor equipment industry; economic conditions in general and as they affect the company's customers; significant fluctuations in the company's quarterly operating results; the impact of rapid technological change; the company's dependence on the development and introduction of new products; the company's concentration on ion implantation systems and related products; concentration in the company's customer base and lengthy sales cycles; the highly competitive market in which the company competes; risks of international sales; foreign currency risks; and general economic conditions; and other factors identified in the company's Annual Report on Form 10-K, and the most recent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. The company cannot guarantee any future results, levels of activity, performance or achievement. The company undertakes no obligation to update any of the forward-looking statements after the date of this press release.



To: Sherman Chen who wrote (1471)11/22/2001 8:15:43 AM
From: Proud_Infidel  Respond to of 1929
 
A V-shaped recovery in 2002?
Don't look now, but an hidden "V"-shaped recovery could be brewing off on the horizon, said veteran chip analyst Bill McClean of IC Insights Inc.

IC Insights is currently predicting a 1% increase in 2002 IC revenues from $119 billion in 2001. Integrated circuit revenues--excluding discrete chip sales--will end up falling 33% in 2001, said McClean.

"The 1% increase in 2002 really masks the V-shaped recovery we are predicting for next year," he said. "That's because we are starting out so low from this year."

The Scottsdale, Ariz.-based research firm is forecasting a 2% sequential revenue drop for IC sales in the first quarter of 2002 from Q4 of 2001, but then the market starts to grow each quarter after that. "We are predicting +5% in Q2 from Q1, +13% in the third quarter, and +14% in Q4," he said.

Currently the IC segment is at revenues of $25-to-$26 billion per quarter, or about a $104 billion run rate. "It will take some pretty good growth rates just to get back to where we are for this year's total," McClean added.--J.R.L.



To: Sherman Chen who wrote (1471)11/26/2001 3:43:38 PM
From: Proud_Infidel  Read Replies (1) | Respond to of 1929
 
TSMC bumps up revenue forecast

By Mike Clendenin
EE Times
(11/26/01 10:38 a.m. EST)

TAIPEI, Taiwan — Things are looking a little better for contract chip maker Taiwan Semiconductor Manufacturing Co., which said Monday (Nov. 26) that it would favorably revise its financial forecast for 2001 because of a surge in orders.

The company said its before-tax revenue would be more than 20 percent higher than predicted in September, putting the foundry's fourth-quarter gross profit at around $271 million. Initially, TSMC had predicted a 15 percent sequential increase in quarterly revenues.

A TSMC spokesman indicated that the increase is due to greater use of its more sophisticated process technologies by customers such as Nvidia Corp., which provides core circuitry for Microsoft's Xbox game console.

TSMC has emerged from this summer's lows on the backs of just a few major companies, like Nvidia and Via Technologies Inc., which have pushed PC-related chips to 49 percent of TSMC's sales. The company estimated that nearly 50 percent of its production lines will be in use this quarter, up from 41 percent in the third quarter. And chairman Morris Chang has also said that the first few months of 2002 shouldn't be any worse than this quarter.



To: Sherman Chen who wrote (1471)12/18/2001 9:03:57 AM
From: Proud_Infidel  Read Replies (2) | Respond to of 1929
 
Varian Wins $775,000 Jury Verdict in Internet Libel Case
Jury Orders Former Employees Michelangelo Delfino and Mary Day to Pay Varian Damages for Defaming and Harassing Company Managers and Their Families
PALO ALTO, Calif.--(BUSINESS WIRE)--Dec. 18, 2001-- Varian Medical Systems, Inc. (NYSE:VAR - news) and Varian Semiconductor Equipment Associates (NASDAQ:VSEA - news) have won a major jury verdict before the Santa Clara County Superior Court today in an Internet defamation and harassment case filed against former employees Michelangelo Delfino and Mary Day. The jury verdict in Varian v. Delfino, 780187, followed a six week trial. The jury awarded Varian Medical Systems, Varian Semiconductor Equipment Associates, Inc., and two of their managers $775,000 in compensatory and punitive damages. In addition, Santa Clara Superior Court Judge Jack Komar, who presided over the case, issued an injunction that prohibits Delfino and Day from continuing to post defamatory and harassing statements on the Internet.

The jury of eight women and four men found unanimously that Delfino and Day acted with malice, fraud, and oppression through some 14,000 Internet postings on 100 message boards and their own web site since 1998 when Delfino was terminated and Day resigned from research positions with Varian Associates. In these messages, Delfino and Day falsely accused various members of Varian management of being homophobic, discriminating against pregnant women, having sexual affairs, and secretly videotaping employees while in office restrooms. Delfino and Day were also charged with impersonating Varian managers on Internet message boards.

``We are thrilled with this result,'' said Lynne Hermle, a partner in Orrick, Herrington & Sutcliffe LLP, which represented Varian in this case. ``Delfino and Day have terrorized and threatened Varian managers and their families. It is a relief that this campaign of defamation and harassment must stop now. Both the judge and the jury have made it clear that the Internet is not a safe haven for defamation.''

The Orrick team who worked on the case, led by Lynne Hermle, included Matthew Poppe and Robert Linton. The team received help before the trial from attorneys Joe Liburt and Pete McMahon. Varian staff attorneys on the case were Mary Rotunno, corporate counsel, and Joseph Phair, vice president and general counsel.

Orrick, Herrington & Sutcliffe LLP is an international law firm of more than 600 lawyers with offices in London, Los Angeles, New York, Sacramento, San Francisco, Seattle, Silicon Valley, Singapore, Tokyo, and Washington D.C.

Varian Semiconductor Equipment Associates is the leading producer of ion implantation equipment used in the manufacture of semiconductors. The company is headquartered in Gloucester, Mass., and operates worldwide. Varian Semiconductor maintains a web site at www.vsea.com. The information contained in the company's web site is not incorporated by reference into this release, and the web site address is included in this release as an inactive textual reference only.

Varian Medical Systems, Inc., (NYSE:VAR - news) of Palo Alto, Calif., is the world's leading manufacturer of integrated cancer therapy systems as well as X-ray tubes and flat-panel sensors for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 2,570 people and reported sales of $774 million in its most recent fiscal year ended September 28, 2001.



To: Sherman Chen who wrote (1471)1/23/2002 4:20:48 PM
From: Proud_Infidel  Read Replies (2) | Respond to of 1929
 
Varian Semiconductor Equipment Associates Reports Fiscal 2002 First Quarter Results
GLOUCESTER, MA--(BUSINESS WIRE)--January 23, 2002--Varian Semiconductor Equipment Associates, Inc. (Nasdaq: VSEA - news) today announced results for its fiscal 2002 first quarter ended December 28, 2001.

Revenue for the fiscal 2002 first quarter totaled $78 million, including $28 million of royalty and license revenue from Lam Research Corporation (Nasdaq: LRCX - news) discussed below. Net income was $5 million, or $0.15 per diluted share. Excluding the Lam royalty and license revenue, the Company's net loss was $12 million, or a $0.37 per share net loss. Revenue for the same period a year ago totaled $226 million, and net income was $41 million, or $1.21 per diluted share before the SAB 101 cumulative effect of accounting change. Shipments, which approximate pre-SAB 101 revenue, excluding the Lam royalty and license revenue, were $45 million for the quarter. An explanation of the Company's adoption of the SAB 101 accounting method is contained in its earnings release of October 25, 2001.

The royalty and license revenue from Lam were for past use of certain patented Varian Semiconductor technology. Under terms of the agreement between the Company and Lam, Varian Semiconductor received a warrant, valued at $23 million, to purchase two million shares of Lam common stock. The royalty and license revenue recorded from Lam in the quarter includes the value of the warrant and a $5 million cash payment received from Lam during the first quarter 2002. Under the agreement, which continues through December 2004, Lam will make $1.25 million royalty and license payments quarterly.

Gross margin in the first quarter of fiscal 2002, excluding the Lam royalty, was 25 percent, as compared to 43 percent for the same period a year ago. The decline in gross margin is primarily a result of lower revenue.

Richard A. Aurelio, Varian Semiconductor's chairman and chief executive officer, said, ``There are signs from customers that indicate that an upturn may not be far off, but our orders do not yet confirm that positive effect. In addition, we see commitment on the part of major customers toward investment in 300mm, and signs of recovery in the DRAM market.''

Aurelio continued, ``The value of our technology has increased customer interest in our single wafer VIISta platform, including our next-generation VIISta 10 P2LAD. We recently signed a joint development agreement with a leading device manufacturer to validate our expectations of the VIISta 10 P2LAD's breakthrough productivity improvement for ultra-shallow junction formation. We anticipate that this program will help propel our innovative technology to broad market acceptance.''

Robert J. Halliday, chief financial officer, added, ``During the first quarter, we generated positive cash flow, while increasing research and development spending from the previous quarter and tightly managing overall operating expenses. Our efforts to respond to short-term economic conditions continue as we pursue long-term priorities for technology development and continued industry leadership.''

Halliday also provided forward guidance, noting that, ``We currently expect revenue for the second fiscal quarter of 2002 to range between $45 and $55 million, and shipments to range as well between $45 and $55 million.''

Varian Semiconductor will hold a conference call, broadcast over the Internet, at 4:30 p.m. eastern time today for analysts, investors and media to discuss the Company's operating results and outlook. Access to the call is available through the Company's web site at www.vsea.com. Replays will be available via the web site for two weeks after the call.

About Varian Semiconductor

Varian Semiconductor Equipment Associates, Inc. is the leading producer of ion implantation equipment used in the manufacture of semiconductors. The Company is headquartered in Gloucester, Massachusetts, and operates worldwide. Varian Semiconductor maintains a web site at www.vsea.com. The information contained in the Company's web site is not incorporated by reference into this release, and the web site address is included in this release as an inactive textual reference only.

Note: This press release contains forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. For this purpose, the statements concerning the industry outlook, the Company's sales growth, market share, capacity utilization and technological improvements and benefits, and any statements using the terms ``believes,'' ``anticipates,'' ``will,'' ``expects,'' ``plans'' or similar expressions, are forward-looking statements. The forward-looking statements involve a number of risks and uncertainties. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volatility in the semiconductor equipment industry; intense competition in the semiconductor equipment industry; the Company's dependence on a small number of customers; fluctuations in the Company's quarterly operating results; the Company's transition to new products; economic problems in Asian-Pacific markets; uncertain protection of the Company's patent and other proprietary rights; concentration in the Company's customer base and lengthy sales cycles; the Company's reliance on a limited group of suppliers; potential environmental liabilities; the Company's dependence on certain key personnel; the Company's limited operating history; and the risk of substantial indemnification obligations under the agreements governing the spin-off of the Company from Varian Associates, Inc. on April 2, 1999. These and other important risk factors that may affect our actual results are discussed in detail under the caption ``Risk Factors'' in the Company's Annual Report on Form 10-K and in other reports filed by the Company with the Securities and Exchange Commission. The Company cannot guarantee any future results, levels of activity, performance or achievement. The Company undertakes no obligation to update any of the forward-looking statements after the date of this press release.

VARIAN SEMICONDUCTOR EQUIPMENT ASSOCIATES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)

Three Months Ended
December 28, December 29,
2001 2000

Revenue

Product revenue $34,138 $ 195,577
Service revenue 14,032 25,491
Royalties 29,610 5,346
Total revenue 77,780 226,414
Cost of revenue 37,697 128,868
Gross profit 40,083 97,546
Operating expenses
Research and development 12,850 13,865
Marketing, general and
administrative 18,948 25,274
Restructuring costs 2,200 -
Total operating expenses 33,998 39,139

Operating income 6,085 58,407
Other income, net 440 -
Interest income, net 1,620 2,043

Income before taxes and cumulative
effect of change in accounting
principle 8,145 60,450
Provision for income taxes 3,095 19,949

Income before cumulative effect of
change in accounting
principle 5,050 40,501
Cumulative effect of change
in accounting principle,
net of tax - (27,038)

Net income $5,050 $ 13,463

Weighted average shares
outstanding - basic 32,690 32,092
Weighted average shares
outstanding - diluted 34,325 33,480

Income per share before cumulative effect
of change in accounting
principle - basic $ 0.15 $ 1.26
Income per share before cumulative effect
of change in accounting
principle - diluted $ 0.15 $ 1.21
Cumulative effect of change in accounting
principle -basic $ - $ (0.84)
Cumulative effect of change in accounting
principle -diluted $ - $ (0.81)
Net income per share
- basic $ 0.15 $ 0.42
Net income per share
- diluted $ 0.15 $ 0.40

VARIAN SEMICONDUCTOR EQUIPMENT ASSOCIATES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

December 28, September 28,
2001 2001

ASSETS
Current assets

Cash and cash equivalents $ 285,214 $ 278,641
Accounts receivable, net 52,916 85,455
Inventories, net 108,073 115,689
Other current assets 46,337 44,525
Total current assets 492,540 524,310

Property, plant and equipment,
net 45,568 46,288
Other assets 40,486 17,459
Total assets $ 578,594 $ 588,057

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Notes payable and other
short-term borrowings $ 12,970 $ 15,900
Accounts payable 17,072 19,271
Accrued expenses 51,937 43,149
Product warranty 14,646 20,075
Deferred revenue 67,021 81,137
Total current liabilities 163,646 179,532

Long-term accrued expenses 7,118 7,292
Deferred taxes 1,897 1,788
Total liabilities 172,661 188,612

Stockholders' equity
Common stock 328 326
Capital in excess of par value 237,134 235,700
Retained earnings 168,471 163,419
Total stockholders' equity 405,933 399,445

Total liabilities and
stockholders' equity $ 578,594 $ 588,057



To: Sherman Chen who wrote (1471)1/29/2002 8:46:38 AM
From: dantecristo  Respond to of 1929
 
Varian is defeated in the US Court of Appeals AGAIN:

biz.yahoo.com